Stockreport

Aptose Biosciences Inc. Announces Pricing of $8 Million Public Offering [Canadian Business Journal (Canada)]

Aptose Biosciences, Inc. - Common Shares  (APTO) 
Last aptose biosciences, inc. - common shares earnings: 3/10 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: aptose.com/investors
PDF SAN DIEGO and TORONTO, Nov. 22, 2024 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology [Read more]